CPhI Worldwide, organized by UBM (part of Informa PLC), announced the finalists of the 2018 CPhI Pharma Awards. This year’s edition features over 250 entries from 174 participating companies across 17 categories, commending the innovations, technologies, and strategies driving pharma forward.
With 139 shortlisted-chemistry, single-use technologies, drug delivery devices, contract services, and packaging among them-the winners will be announced during a live awards ceremony taking place at the Eurostars Madrid Tower Hotel on October 9-the opening day of CPhI Worldwide.
To see the complete list of finalists, please visit: https://awards.cphi.com/finalists/.
The awards will be presented at the CPhI Awards Gala. For more information visit:https://awards.cphi.com/attend-the-gala/.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.